期刊文献+

经尿道前列腺等离子剜除术治疗伴有经直肠前列腺活检病史的良性前列腺增生患者的有效性和安全性 被引量:6

Efficacy and safety of transurethral plasmakinetic enucleation of prostate in the treatment of benign prostatic hyperplasia patients with a history of transrectal prostate biopsy
下载PDF
导出
摘要 目的探究经尿道前列腺等离子剜除术(PKEP)治疗伴有经直肠前列腺活检(TRPB)病史的良性前列腺增生(BPH)患者的有效性和安全性。方法选取我院2018年1月至2020年12月收治的40例TRPB后进行PKEP的BPH患者作为观察组,选取同期我院40例PKEP术前未实施TRPB的BPH患者作为对照组;回顾性分析两组患者的临床资料。比较两组的手术指标、膀胱残余尿量(RUV)、最大尿流率(MFR)及并发症发生情况。结果观察组的手术时间长于对照组(P<0.05);且观察组中,PKEP术与TRPB间隔≥2周患者的手术时间短于<2周患者(P<0.05);两组的术中出血量、膀胱冲洗时间、尿管留置时间比较,差异无统计学意义(P>0.05)。术后3个月,两组的RUV低于术前,MFR高于术前(P<0.05)。两组的并发症总发生率比较,差异无统计学意义(P>0.05)。结论PKEP治疗伴有TRPB病史的BPH患者安全可行,PKEP术与TRPB间隔2周及以上能够降低手术难度,缩短手术时间。 Objective To explore the efficacy and safety of transurethral plasmakinetic enucleation of prostate(PKEP)in the treatment of benign prostatic hyperplasia(BPH)patients with a history of transrectal prostate biopsy(TRPB).Methods A total of 40 BPH patients with PKEP after TRPB admitted in our hospital from January 2018 to December 2020 were selected as observation group,and 40 BPH patients without TRPB before PKEP in our hospital in the same period were selected as control group;the clinical data of patients in the two groups were analyzed retrospectively.The operative indexes,residual urinary volume(RUV),maximum urinary flow rate(MFR)and complications were compared between the two groups.Results The operation time in the observation group was longer than that in the control group(P<0.05);and in the observation group,the operation time in patients with an interval of≥2 weeks between PKEP and TRPB was shorter than that in patients with an interval of<2 weeks(P<0.05);there were no significant differences in the intraoperative bleeding,bladder flushing time and urinary catheter retention time between the two groups(P>0.05).Three months after operation,the RUV of the two groups was lower than that before operation,and the MFR was higher than that before operation(P<0.05).There was no significant difference in the total incidence of complications between the two groups(P>0.05).Conclusion PKEP in the treatment of BPH patients with a history of TRPB is safe and feasible.The interval between PKEP and TRPB of 2 weeks or more can reduce the difficulty of operation and shorten the operation time.
作者 谢益敏 秦振乾 袁雪锋 蒋旭平 XIE Yimin;QIN Zhenqian;YUAN Xuefeng;JIANG Xuping(Yixing People's Hospital,Yixing 214200,China)
出处 《临床医学研究与实践》 2022年第3期28-30,共3页 Clinical Research and Practice
基金 无锡市卫生计生委科研项目(2018版)(No.Q201807) 2020年度无锡市科技发展医疗卫生指导性计划项目(锡科社[2020]259号)。
关键词 良性前列腺增生 经尿道前列腺等离子剜除术 经直肠前列腺活检 benign prostatic hyperplasia transurethral plasmakinetic enucleation of prostate transrectal prostate biopsy
  • 相关文献

参考文献15

二级参考文献147

  • 1范洪力.良性前列腺增生症证候临床研究[J].中国医药指南,2008,6(23):401-402. 被引量:8
  • 2张亚大,卢子杰,顾晓箭,张平,徐彦,黄树纲.500例良性前列腺增生症中医证型与临床相关因素分析[J].南京中医药大学学报,2004,20(5):281-283. 被引量:11
  • 3李培军,张祥华,郭利君,那彦群.高血压对良性前列腺增生细胞增殖与凋亡的影响[J].中华男科学杂志,2005,11(2):94-97. 被引量:31
  • 4阙艳红,王学梅.双平面经直肠超声诊断良性前列腺增生的探讨[J].中华男科学杂志,2005,11(3):191-194. 被引量:13
  • 5杜元灏,李晶,孙冬纬,刘维红,李桂平,林雪,任辉,王涵,邹蓓蕾,焦素林,黄卫.中国现代针灸病谱的研究[J].中国针灸,2007,27(5):373-378. 被引量:278
  • 6Shim SR,Kim JH,Choi H,et al.Association between the self-perception period of lower urinary tract symptoms and the International Prostate Symptom Score.Urologia Internationalis,2012,88(4):431-437.
  • 7Hatzimouratidis K.A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction.Ther Adv Urol,2014,6(4):135-147.
  • 8Shore N.A Review of the prostatic urethral lift for lower urinary tract symptoms:symptom relief,flow improvement,and preservation of sexual function in men with benign prostatic hyperplasia.Curr Bladder Dysfunct Rep,2015,10(2):186-192.
  • 9Novara G,Chapple CR,Montorsi F.A pooled analysis of individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms(LUTS)suggestive of benign prostatic hyperplasia(BPH).BJU international,2014,114(3):427-433.
  • 10Aggarwal S,Verma A,Shukla R,et al.An overview of phytotherapeutic approaches for the treatment of benign prostatic hyperplasia.Mini Rev Med Chem,2014,14(3):257-270.

共引文献552

同被引文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部